Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - RESEARCH & DEVELOPMENT
Research & Development FATE - Fate Therapeutics, Inc.
173 M
LAST VALUE
-10.51%
2 YEAR CAGR
25.24%
5 YEAR CAGR
30.54%
10 YEAR CAGR